(Reuters) – The US Supreme Court on Monday rejected another Bayer AG bid to dismiss lawsuits alleging that its Roundup herbicide causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages.
The judges rejected an appeal from Bayer, leaving a lower court order upholding an $ 87 million verdict handed down in a California lawsuit to Alberta and Alva Pilliod, who was diagnosed with cancer after spraying Roundup for more than three decades. On June 21, the Supreme Court rejected Bayer’s appeal in another Roundup case.
Bayer has claimed that the cancer claims over Roundup and its active ingredient glyphosate run counter to sound science and product approval from the US Environmental Protection Agency. Bayer̵7;s appeal in the Pilliod case posed a further challenge, arguing that awarding criminal damages that far outweighs compensatory damages would violate the legal protection of the US Constitution.
Alva and Alberta Pilliod were both diagnosed with non-Hodgkin’s lymphoma, a type of lymphoma, after decades of using Roundup. A California judge reduced the $ 2 billion jury’s $ 2020 target in the case to $ 87 million. California’s Supreme Court ruled last year Bayer’s appeal of the $ 87 million award.